Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXL in Infectious Keratitis
NCT02088970Terminated
- Sponsor
- CHU de Nantes
- Start
- Sep 2014
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
Randomised, open-label trial in bacterial keratitis and fungal keratitis (FK), sponsored by CHU de Nantes. Primary endpoint: Duration of corneal complete epithelial healing at 3 months. Started Sep 2014; status: terminated.
02
Conditions
bacterial keratitisfungal keratitis (FK)
Beyond the preview
Go deeper on NCT02088970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088970.